Harter Secrest & Emery LLP assisted Athenex, Inc., while the underwriter was represented by Latham & Watkins LLP. Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Gemini, while Goodwin Procter advised Disc Medicine. Fried, Frank, Harris, Shriver & Jacobson acted as counsel to SVB Securities...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriter, SVB Securities, in the offering. Applied Therapeutics, Inc. announced its offering of 20,000,000 shares of common stock, pre-funded warrants to purchase up...
You must be a Standard 1 Year member to access this content.
Homburger advised VectivBio on the deal. NKF acted as Swiss counsel to SVB Securities, Piper Sandler and LifeSci Capital in the public offering. VectivBio Holding AG (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Gide advised Goldman Sachs and SVB Leerink LLC. McDermott Will & Emery advised DBV Technologies. DBV Technologies, a clinical-stage biopharmaceutical company, announced a private placement financing...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Chinook Therapeutics, Inc. (Nasdaq: KDNY) has announced the pricing of its underwritten public offering of 6,428,572 shares...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the IPO while Goodwin advised PepGen. PepGen, Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with...
You must be a Standard 1 Year member to access this content.
O’Melveny & Myers represented Nkarta, while Shearman & Sterling represented Cowen and Company, LLC, SVB Securities LLC and Evercore Group L.L.C., as representatives of the underwriters,...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard, working alongside Walkers, instructed by onshore law firm Gibson, Dunn & Crutcher LLP, advised MoonLake Immunotherapeutics AG on this transaction. Pestalozzi advised Helix Acquisition...
You must be a Standard 1 Year member to access this content.
